Impact of PKM linkers on biodistribution characteristics of the 99mTc-labeled cyclic RGDfK dimer
- PMID: 17105229
- PMCID: PMC2562319
- DOI: 10.1021/bc060235l
Impact of PKM linkers on biodistribution characteristics of the 99mTc-labeled cyclic RGDfK dimer
Abstract
This report describes synthesis of three new cyclic RGDfK peptide conjugates, HYNIC-PKM-SU016 (PKM = E, K and PEG4) and in vivo evaluation of the impact of PKM linkers on biodistribution characteristics of their ternary ligand complexes [99mTc(HYNIC-PKM-SU016)1(tricine)(TPPTS)] in athymic nude mice bearing the MDA-MB-435 human breast cancer xenografts. Results from biodistribution studies show that PKM linkers have minimal impact on the integrin alphavbeta3 binding capability of radiotracers. Even though they have different charges under physiological conditions, all three linkers (E, K, and PEG4) are able to reduce the uptake of 99mTc-labeled E[c(RGDfK)]2 in blood, kidneys, liver, and lungs, and increase target-to-background (T/B) ratios at >30 min postinjection. E and K may have advantages over PEG4 due to a combination of relatively low liver uptake and high tumor/liver and tumor/lung ratios of ternary ligand complexes [99mTc(HYNIC-PKM-SU016)(tricine)(TPPTS)] (PKM = E and K).
Figures







Similar articles
-
Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.Mol Pharm. 2009 Jan-Feb;6(1):231-45. doi: 10.1021/mp800150r. Mol Pharm. 2009. PMID: 19067525 Free PMC article.
-
Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer.Bioconjug Chem. 2005 Nov-Dec;16(6):1580-8. doi: 10.1021/bc0501653. Bioconjug Chem. 2005. PMID: 16287258
-
Evaluation of 99mTc-labeled cyclic RGD dimers: impact of cyclic RGD peptides and 99mTc chelates on biological properties.Bioconjug Chem. 2012 Mar 21;23(3):586-95. doi: 10.1021/bc200631g. Epub 2012 Mar 6. Bioconjug Chem. 2012. PMID: 22369387 Free PMC article.
-
111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,710,13-tetraoxapentadecanoic acid).2012 Feb 23 [updated 2012 Mar 22]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2012 Feb 23 [updated 2012 Mar 22]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 22457887 Free Books & Documents. Review.
-
111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,7,10,13-tetraoxapentadecanoic acid).2012 Feb 23 [updated 2012 Mar 22]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2012 Feb 23 [updated 2012 Mar 22]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 22457890 Free Books & Documents. Review.
Cited by
-
Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins.Bioconjug Chem. 2015 Aug 19;26(8):1413-38. doi: 10.1021/acs.bioconjchem.5b00327. Epub 2015 Aug 3. Bioconjug Chem. 2015. PMID: 26193072 Free PMC article. Review.
-
Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging.Biophys Rep. 2016;2(1):1-20. doi: 10.1007/s41048-016-0021-8. Epub 2016 Apr 12. Biophys Rep. 2016. PMID: 27819026 Free PMC article. Review.
-
2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics.Bioconjug Chem. 2009 Aug 19;20(8):1559-68. doi: 10.1021/bc9001739. Epub 2009 Jul 15. Bioconjug Chem. 2009. PMID: 19603780 Free PMC article.
-
Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT.Theranostics. 2011 Jan 18;1:58-82. doi: 10.7150/thno/v01p0058. Theranostics. 2011. PMID: 21547153 Free PMC article.
-
Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers.Bioconjug Chem. 2009 Apr;20(4):750-9. doi: 10.1021/bc800455p. Bioconjug Chem. 2009. PMID: 19320477 Free PMC article.
References
-
- Liu S, Edwards DS, Ziegler MC, Harris AR, Hemingway SJ, Barrett JA. 99mTc-Labeling of a hydrazinonicotinamide-conjugated vitronectin receptor antagonist useful for imaging tumors. Bioconj. Chem. 2001;12:624–629. - PubMed
-
- Liu S, Hsieh WY, Kim YS, Mohammed SI. Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer. Bioconj. Chem. 2005;16:1580–1588. - PubMed
-
- Jia B, Shi J, Yang Z, Xu B, Liu Z, Zhao H, Liu S, Wang F. 99mTc-labeled yclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin αvβ3 expression. Bioconj. Chem. 2006;17:1069–1076. - PubMed
-
- Liu S, Hsieh W-Y, Jiang Y, Kim Y-S, Sreerama SG, Chen XY, Jia B, Wang F. Evaluation of a 99mTc-labeled cyclic RGD tetramer for non-invasive imaging integrin αvβ3-positive breast cancer. J. Nucl. Med. Submitted.
-
- Chen XY, Liu S, Hou YP, Tohme M, Park R, Bading JR, Conti PS. MicroPET imaging of breast cancer αvβ3-integrin expression with 64Cu-labeled dimeric RGD peptides. Mol. Imag. Biol. 2004;6:350–359. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous